gemcitabine,irinotecan
not tagged
['great work', 'pancreatic', 'congrat', 'neopan', 'gemcitabine']
#esmo22 provided positive phase iii results in pancreatic cancer : neopan trial: gemcitabine vs folfirinox . primary endpoint met: longer pfs however os no difference looking forward to getting further data. congrats for this great work 
Independent and international experts in GI oncology supporting medical oncologists to give the best possible care to patients. Part of https://t.co/Y8pV8OaxOB